Fatty acid therapy and compositions for the treatment of myalgic

Details Fatty acid therapy and compositions for the treatment of myalgic Fatty acid therapy and compositions for the treatment of myalgic

1989-08-24

1992-05-26

Griffin, Ronald W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

514558, 514783, 4241951, A61K 3120, A61K 3578

Patent

active

051168715

ABSTRACT:
The use of one or more of the 6-desaturated or higher EFAs of each of the n-6 and n-3 series for the manufacture of a medicament for use in the treatment of post-viral fatigue syndrome (otherwise known as myalgic encephalomyelitis (ME)).

REFERENCES:
patent: 4388324 (1983-06-01), Horrobin
patent: 4513008 (1985-04-01), Revici et al.
patent: 4535093 (1985-08-01), Horrobin
patent: 4910224 (1990-03-01), Habib
Lipids vol. 23, No. 10, Oct. 1988, pp. 981-988 Williams et al Serum fatty acid proportions are altered . . . Epstein-Barr virus infection.
Annals of Internal Medicine vol. 106, No, 4, Apr. 1987, pp. 497-503 Am College Physicians, Kremer et al. Fish-oil fatty acid . . . in arthritis.
Merck Manual of Diagnosis and Therapy 15th edition R. Berkow M. D. Editor 1987 pp. 46-49 "Antiviral Drugs".
Grasmus, Udo Fats and Oils, 1986 Vancouver Can. pp. 250-254.
The Merck Index 11th Ed. 1989 Merck & Co., Rahway, NJ #3495.

Affiliated with

Also associated with

Rating

Fatty acid therapy and compositions for the treatment of myalgic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fatty acid therapy and compositions for the treatment of myalgic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fatty acid therapy and compositions for the treatment of myalgic will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-420393